Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Treatment Protocol for Selective Laser Trabeculoplasty

NCT03798223 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT03798223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03798223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Treatment Protocol for Selective Laser Trabeculoplasty
Lead sponsor
Vastra Gotaland Region
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 10, 2019
Completion date
December 31, 2027
Enrollment
400 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, open-angle, ocular hypertension, pseudoexfoliation glaucoma